J. Goldman & Co’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $32.2K | Hold |
|
|||||
|
2023
Q2 | $38.5K | Hold |
|
|||||
|
2023
Q1 | $39.4K | Hold |
|
|||||
|
2022
Q4 | $44.8K | Hold |
|
|||||
|
2022
Q3 | $35K | Sell |
|
|||||
|
2022
Q2 | $186K | Sell |
|
|||||
|
2022
Q1 | $1.58M | Buy |
|
|||||
|
2021
Q4 | $508K | Buy |
|
|||||
|
2021
Q3 | $255K | Sell |
|
|||||
|
2021
Q2 | $1.38M | Buy |
|
|||||
|
2021
Q1 | $165K | Sell |
|
|||||
|
2020
Q4 | $354K | Sell |
|
|||||
|
2020
Q3 | $2.02M | Sell |
|
|||||
|
2020
Q2 | $1.88M | Buy |
|
|||||
|
2020
Q1 | $457K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $2.95M | Sell |
|
|||||
|
2017
Q4 | $3.83M | Buy |
|
|||||
|
2017
Q3 | $2.38M | Buy |
|
|||||
|
2017
Q2 | $1.63M | Buy |
|
|||||
|
2017
Q1 | $1.64M | Sell |
|
|||||
|
2016
Q4 | $1.86M | Buy |
|
|||||
|
2016
Q3 | $1.32M | Sell |
|
|||||
|
2016
Q2 | $1.63M | Buy |
|
|||||
|
2016
Q1 | $861K | Buy |
|